Morphology of liver repair following cholestatic liver injury: resolution of ductal hyperplasia, matrix deposition and regression of myofibroblasts.
OBJECTIVE
Myofibroblasts are the primary cells responsible for increased matrix deposition in hepatic fibrosis. Activation of hepatic stellate cells and portal fibroblasts to myofibroblasts during cholestatic liver injury is accompanied by increased expression of the activation marker, alpha-smooth muscle actin (SMA), and collagen genes. In contrast to our understanding of injury, the cellular mechanisms of liver repair are not well defined. This study was designed to examine the morphological relationship between bile duct hyperplasia, matrix deposition and myofibroblast phenotype in a model of chronic cholestatic liver injury and repair.


METHODS
Reversible extrahepatic obstruction was accomplished in rats using a soft vessel loop suspended from the anterior abdominal wall: duct manipulation alone was performed in sham-operated controls. After 7 days, rats were either sacrificed or decompressed by release of the loop and subsequently sacrificed 2-10 days after reversal. Liver sections were obtained for in situ hybridization for procollagen alpha1(I) mRNA, immunohistochemical staining for SMA and cytokeratin 19, and histochemical staining for reticulin.


RESULTS
Cholestatic livers demonstrated bile duct hyperplasia, which reversed to normal within 10 days after decompression. Fibrosis was also substantially reduced during this period. SMA-positive myofibroblasts were abundant and localized to regions adjacent to proliferating ducts and excess matrix in the obstructed animals. Decompressed livers showed a dramatic time-dependent reduction in the number of SMA-positive cells and in the expression of procollagen I mRNA.


CONCLUSIONS
Our results show that the disappearance of bile duct hyperplasia after biliary decompression is accompanied by a similarly rapid loss of SMA-positive myofibroblasts. Both cellular events may abrogate enhanced matrix synthesis and allow repair to occur.
Ramm
G A
GA
Queensland Institute of Medical Research, Brisbane, Australia.
Carr
S C
SC
Bridle
K R
KR
Li
L
L
Britton
R S
RS
Crawford
D H
DH
Vogler
C A
CA
Bacon
B R
BR
Tracy
T F
TF
D000199:Actins / Q000378:metabolism; D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001652:Bile Ducts / Q000378:metabolism / Q000473:pathology*; D001663:Bilirubin / Q000097:blood; D001651:Cholestasis, Extrahepatic / Q000150:complications / Q000378:metabolism / Q000473:pathology*; D002908:Chronic Disease; D004195:Disease Models, Animal; D005109:Extracellular Matrix / Q000378:metabolism*; D005347:Fibroblasts / Q000166:cytology / Q000502:physiology*; D006651:Histocytochemistry; D006965:Hyperplasia / Q000150:complications / Q000378:metabolism / Q000473:pathology*; D007633:Keratins / Q000378:metabolism; D008099:Liver / Q000378:metabolism* / Q000473:pathology; D008106:Liver Cirrhosis, Experimental / Q000150:complications / Q000378:metabolism / Q000473:pathology; D008115:Liver Regeneration; D008297:Male; D011347:Procollagen / Q000235:genetics; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D012155:Reticulin / Q000378:metabolism; D005723:gamma-Glutamyltransferase / Q000097:blood
D000199:Actins; D011347:Procollagen; D012333:RNA, Messenger; D012155:Reticulin; D007633:Keratins; D005723:gamma-Glutamyltransferase; D000410:Alanine Transaminase; D001663:Bilirubin